| Siri J Fiebiger, MD | |
|
2925 Chicago Ave, Minneapolis, MN 55407-1321 | |
| (612) 863-4000 | |
| Not Available |
| Full Name | Siri J Fiebiger |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 2925 Chicago Ave, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073544995 | NPI | - | NPPES |
| 28132FI | Other | ND | MNBS # |
| ND200016 | Other | ND | LHS # |
| 142008 | Other | ND | UCARE # |
| 10283 | Other | ND | NDBS # |
| 2250 | Other | ND | SIOUX VALLEY # |
| 0702341 | Other | ND | MEDICA # |
| 4703 | Other | ND | NDBS # |
| 900855 | Other | ND | AMERICA'S PPO/ARAZ # |
| 16449 | Medicaid | ND | |
| 6D408FI | Other | ND | MNBS # |
| DA9011015532 | Other | ND | PREFERRED ONE # |
| 197002000 | Medicaid | ND | |
| 0701548 | Other | ND | MEDICA # |
| HP19513 | Other | ND | HEALTHPARTNERS # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5961 (North Dakota) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 44323 (Minnesota) | Primary |
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
With the country on course to enshrine the rights of transgender Americans, Wren Vetens introduced herself as a woman for the first time in January 2016, at the annual meeting of the American Astronomical Society.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany from November 16 to19, 2010.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Australian researchers from the Murdoch Children's Research Institute have come up with a latest study results showing that peanut allergy could be treated successfully with an immune-based therapy. This new therapy helped children allergic to peanuts eat these nuts with no reactions for up to four years. The study appeared this week in the journal Lancet Child & Adolescent Health.
A group of researchers in Israel, the United States and other nations have made important advances in the rapidly-expanding field of "regenerative medicine," outlining for the first time connections in genetic regulation that normally prevent birth defects in heart and facial muscles.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Siri J Fiebiger, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Siri J Fiebiger, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 863-4000 |
News Archive
With the country on course to enshrine the rights of transgender Americans, Wren Vetens introduced herself as a woman for the first time in January 2016, at the annual meeting of the American Astronomical Society.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany from November 16 to19, 2010.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Australian researchers from the Murdoch Children's Research Institute have come up with a latest study results showing that peanut allergy could be treated successfully with an immune-based therapy. This new therapy helped children allergic to peanuts eat these nuts with no reactions for up to four years. The study appeared this week in the journal Lancet Child & Adolescent Health.
A group of researchers in Israel, the United States and other nations have made important advances in the rapidly-expanding field of "regenerative medicine," outlining for the first time connections in genetic regulation that normally prevent birth defects in heart and facial muscles.
› Verified 9 days ago
David Charles Nagel, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 606 24th Ave S, Suite 700, Minneapolis, MN 55454 Phone: 612-672-2450 | |
Jessica L Nyholm, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 606 24th Ave S, Suite 400, Minneapolis, MN 55454 Phone: 612-273-2223 | |
Mr. Clifton O Brock, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 902 E 26th St Ste 1700, Minneapolis, MN 55404 Phone: 612-863-4502 | |
John W Hering, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2220 Riverside Ave, Mail Stop 31700a, Minneapolis, MN 55454 Phone: 612-371-1600 Fax: 612-371-1732 | |
Marilyn Susan Joseph, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 410 Church St Se, Boynton Health Service, Minneapolis, MN 55455 Phone: 612-625-5187 Fax: 612-625-0902 | |
Dr. Jennifer Martha Mckeand, MD MS Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 South 8th St Suite 600, Womens Health Consultants, Minneapolis, MN 55402 Phone: 612-333-4822 Fax: 612-333-3108 | |
Dr. Amanda Leigh Boozalis, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3270 W Lake St, Minneapolis, MN 55416 Phone: 612-775-1800 Fax: 612-775-1805 |